Comparison of Polysomnographic Characteristics in Geriatric and Adult Patients

Yıl 2024, Cilt: 21 Sayı: 2, 85 - 94, 30.05.2024

Müjgan Ercan , Abdullah Gürel , Mehmet Özcan , Ahmet Dumanlı , Melis Arslan , Rida Nur Deniz

Öz

Objectıve: Determining the prognostic factors in patients diagnosed with prostate cancer is important in terms of patient follow-up and treatment process. In this study, it was aimed to retrospectively examine the Nutrition Status score (CONUT score), which is the nutritional status marker of prostate cancer patients.
Material and Methods: In this retrospective study, the laboratory findings (lymphocyte, albumin and total cholesterol results) of 100 patients who were followed up in the Urology Department of Afyonkarahisar Health Sciences University Hospital in 2021 were retrospectively reviewed. A total of 40 followed-up patients with three parameters as a result of the screening were included in the study. CONUT score was calculated according to serum albumin, total cholesterol and lymphocyte levels.
Results: The mean age of the 40 patients included in the study for the CONUT score was 69±7. Patients were divided into two groups as localized and metastatic prostate cancer. While the median value of CONUT score was 1(0-5) in patients with localized prostate cancer, it was 2(0-7) in metastatic prostate cancer. However, the difference between these two groups was not statistically significant (p= 0.248).
Conclusion: We found that the CONUT score was not a significant predictor in terms of statistical significance in the nutritional follow-up of prostate cancer patients. This is the first study to evaluate nutrition in prostate cancers. However, due to the limited number of patients included in the study, prospective studies with larger patient populations are needed.

Anahtar Kelimeler

Nutritional Status score, prognosis control, prostate cancer

Prostat Kanserlerinde Conut Skorunun Değerlendirilmesi

Öz

Giriş: Prostat kanseri tanısı alan hastalarda prognostik faktörleri saptamak hastanın takibi ve tedavi süreci açısından önemlidir. Bu çalışmada prostat kanserli hastaların beslenme durum belirteçleri olan Beslenme Durumu skorunun (CONUT skoru) retrospektif olarak incelenmesi amaçlanmıştır.
Materyal ve Metod: Retrospektif olan bu çalışma Afyonkarahisar Sağlık Bilimleri Üniversite Hastanesi Üroloji Anabilim Dalı'nda 2021 yılında takipli 100 hastanın laboratuvar bulguları (lenfosit, albumin ve total kolesterol sonuçları) geriye dönük tarandı. Taranma sonucunda üç parametrenin olduğu toplam 40 takipli hasta çalışmaya dahil edildi. CONUT skoru, serum albumin, total kolesterol ve lenfosit seviyelerine göre hesaplandı.
Bulgular: CONUT skoru için çalışmaya dahil edilen 40 hastanın yaş ortalaması 69±7 idi. Hastalar lokalize ve metastatik prostat kanseri olarak iki gruba ayrıldı. Lokalize prostat kanseri olan hastalarda CONUT skorunun medyan değeri 1(0-5) iken, metastatik prostat kanserinde 2(0-7) olarak tespit edildi. Ancak bu iki grup arasındaki fark istatistiksel olarak anlamlı bulunmadı(p= 0,248).
Sonuç: Prostat kanseri hastalarının nutrisyon izleminde CONUT skorunun istatiksel anlamlılık bakımından anlamlı bir belirteç olamadığını tespit ettik. Bu çalışma prostat kanserlerinde nütrisyonu değerlendiren ilk çalışmadır. Ancak çalışmaya dahil edilen hasta sayısının kısıtlı olması nedeniyle bu konuda daha geniş hasta popülasyonları ile yapılan prospektif çalışmalara ihtiyaç duyulmaktadır.

Anahtar Kelimeler

Beslenme Durumu skoru, prognoz kontrolü, prostat kanseri

Kaynakça

• Buzby, G. P., Mullen, J. L., Matthews, D. C., Hobbs, C. L., Rosato, E. F. (1980). Prognostic nutritional index in gastrointestinal surgery. Am J Surg, 139, 160–7.
• Champ, C. E., Mishra, M. V., Showalter, T. N., Ohri, N., Dicker, A. P., Simone, N. L. (2013). Dietary recommendations during and after cancer treatment: Consistently inconsistent? Nutr Cancer, 65(3), 430–9.
• Hayıroğlu, M. İ., Keskin, M., Keskin, T., Uzun, A. O., Altay, S., Kaya, A., et al. (2018). A novel independent survival predictor in pulmonary embolism: Prognostic nutritional index. Clin Appl Thromb Hemost, 24, 633–9.
• Ignacio de Ulíbarri, J., González-Madroño, A de Villar, N. G., González, P., González B, Mancha A, et al. (2005). CONUT: A tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp, Jan-Feb; 20(1), 38-45. PMID: 15762418.
• Jiang, S. S., Weng, D. S., Jiang, L., Zhang, Y. J., Pan, K., Pan, Q. Z., et al. (2016). The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer, 7(6), 626–32.
• Kanemasa, Y., Shimoyama, T., Sasaki, Y., Hishima, T., Omuro, Y. (2018). Geriatric nutritional risk index as a prognostic factor in patients with diffuse large b cell lymphoma. Ann Hematol, Jun, 97 (6), 999-1007. doi: 10.1007/s00277-018-3273-1.
• Kim, B. S. (2020). Prognostic Significance of Preoperative Controlling Nutritional Status Score in Patients Who Underwent Hepatic Resection for Hepatocellular Carcinoma. J Liver Cancer, Sep, 20(2), 106-112. doi: 10.17998/jlc.20.2.106.
• Klute, K. A., Brouwer, J., Jhawer, M. (2016). Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis. Eur J Cancer, 63, 189–200.
• Kuroda, D., Sawayama, H., Kurashige, J., Iwatsuki, M., Eto, T., Tokunaga, R., et al. (2018). Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer, Mar, 21(2), 204-212.
• Narumi, T., Arimoto, T., Funayama, A., Kadowaki, S., Otaki, Y., Nishiyama, S., et al. (2013). Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol , 62, 307–13.
• Onodera, T., Goseki, N., Kosaki, G. (1984). Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi, 85, 1001–5.
• Peng, L., Meng, C., Li, J., You, C., Du, Y., Xiong, W., et al. (2022). The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: A systematic review and meta-analysis. Eur J Clin Nutr, Jun, 76(6), 801-810.
• Peng, L., Meng, C., Li, J., You, C., Du, Y., Xiong, W., et al. (2022). The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: A systematic review and meta-analysis. Eur J Clin Nutr, Jun, 76(6), 801-810.
• Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., Mashele, S. (2022). Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules. Sep 5, 27(17), 5730. doi: 10.3390/molecules27175730.
• Takamori, S., Toyokawa, G., Taguchi, K., Edagawa, M., Shimamatsu, S., Toyozawa, R., et al. (2017). The controlling nutritional status score is a significant independent predictor of poor prognosis in patients with malignant pleural mesothelioma. Clin Lung Cancer, Ju, 18 (4): e303-e313. doi: 10.1016/j.cllc.2017.01.008 .
• Ureshino, H., Kusaba, K., Kidoguchi, K., Sano, H., Nishioka, A., Itamura, H., et al. (2019). Clinical impact of the CONUT score and mogamulizumab in adult t cell leukemia/lymphoma. Ann Hematol, Feb; 98 (2), 465-471. doi: 10.1007/s00277-018-3502-7.
• Yamamoto, M., Saito, H., Uejima, C., Tanio, A., Tada, Y., Matsunaga, T., et al. (2019). Prognostic value of combined tumor marker and controlling nutritional status (CONUT) score in colorectal cancer patients. Yonago Acta Med, Mar 28, 62 (1), 124-130. doi:10.33160/ yam.2019.03.017